Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05753813
EARLY_PHASE1
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
Sponsor: Queen's Medical Center
View on ClinicalTrials.gov
Summary
This project aims to investigate if the contraceptive method, Phexxi, causes changes to the composition of the vaginal microbiome. The investigators hypothesize that regular use of Phexxi will cause increased colonization of lactic acid-producing lactobacilli, which could have positive effects in the way of preventing recurrent episodes of BV and candida infections.
Key Details
Gender
FEMALE
Age Range
18 Years - 54 Years
Study Type
INTERVENTIONAL
Enrollment
22
Start Date
2023-12-15
Completion Date
2026-12-30
Last Updated
2026-02-20
Healthy Volunteers
Yes
Interventions
DRUG
Phexxi
intravaginal gel twice weekly for 4 weeks.
Locations (1)
Queens Medical Center, 1004 Clinic POB1
Honolulu, Hawaii, United States